Diabetic retinopathy: Neuron protection as a therapeutic target

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 7, 2013, Pages 1525-1529

  Zhang, Xinyuan ^a,d   Wang, Ningli ^a   Barile, Gaetano R ^b   Bao, Shisan ^c   Gillies, Mark ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b EAR AND THROAT HOSPITAL   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Diabetic Retinopathy; Microvasculopathy; Neuropathy; Treatment

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID DERIVATIVE; CASPASE 3; ERYTHROPOIETIN; GLUCOCORTICOID; INSULIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PIGMENT EPITHELIUM DERIVED FACTOR; ROSIGLITAZONE; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN ANTIBODY; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; COLOR VISION TEST; CONTRAST SENSITIVITY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG TARGETING; ELECTRORETINOGRAPHY; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MICROVASCULARIZATION; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERIMETRY; RETINA BLOOD VESSEL; RETINA GANGLION CELL; SCANNING LASER POLARIMETRY; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; VITRECTOMY; MACULAR EDEMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY;

APOPTOSIS; CASPASE 3; DIABETIC RETINOPATHY; HUMANS; HYPERGLYCEMIA; MACULAR EDEMA; NEOVASCULARIZATION, PATHOLOGIC; NEUROPROTECTIVE AGENTS;

EID: 84878828852     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.03.002     Document Type: Short Survey

References (38)

1. J. Ambati Elevated gamma-aminobutyric acid: glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy Archives of Ophthalmology 115 9 1997 1161 1166 (Pubitemid 27387953)
2. D.A. Antonetti Diabetic retinopathy: seeing beyond glucose-induced microvascular disease Diabetes 55 9 2006 2401 2411 (Pubitemid 44871140)
3. A.J. Barber Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin Journal of Clinical Investigation 102 4 1998 783 791 (Pubitemid 28399611)
4. R.B. Bhisitkul Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage Investigative Ophthalmology and Visual Science 2008
5. Diabetes Control and Complications Trial Research Group The effect of internsive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus New England Journal of Medicine 329 1993 977 986
6. A.B. El-Remessy Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite American Journal of Pathology 163 5 2003 1997 2008 (Pubitemid 37310030)
7. A.B. El-Remessy Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes American Journal of Pathology 168 1 2006 235 244 (Pubitemid 43062576)
8. D.C. Fernandez Early distal axonopathy of the visual pathway in experimental diabetes American Journal of Pathology 180 1 2012 303 313
9. B. Fortune, M.E. Schneck, and A.J. Adams Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy Investigative Ophthalmology and Visual Science 40 11 1999 2638 2651 (Pubitemid 29455495)
10. M.C. Gillies Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial Ophthalmology 113 9 2006 1533 1538 (Pubitemid 44292310)
11. F. Guilloton Granzyme B induction signalling pathway in acute myeloid leukemia cell lines stimulated by tumor necrosis factor alpha and fas ligand Cellular Signalling 19 6 2007 1132 1140 (Pubitemid 46561551)
12. H.P. Hammes, H.J. Federoff, and M. Brownlee Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes Molecular Medicine 1 5 1995 527 534
13. B.F. Hogewind Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis European Journal of Ophthalmology 18 3 2008 429 434
14. J.E. Johnson Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells Journal of Neuroscience 6 10 1986 3031 3038 (Pubitemid 16026084)
15. T.S. Kern, and A.J. Barber Retinal ganglion cells in diabetes The Journal of Physiology 586 18 2008 4401 4408
16. T.S. Kern, and A.J. Barber Retinal ganglion cells in diabetes Journal of Physiology 586 Pt 18 2008 4401 4408
17. R.A. Kowluru Retinal glutamate in diabetes and effect of antioxidants Neurochemistry International 38 5 2001 385 390 (Pubitemid 32166895)
18. E. Lieth Retinal neurodegeneration: early pathology in diabetes Clinical and Experimental Ophthalmology 28 1 2000 3 8 (Pubitemid 30433242)
19. M.M. Loeliger, T. Briscoe, and S.M. Rees BDNF increases survival of retinal dopaminergic neurons after prenatal compromise Investigative Ophthalmology and Visual Science 49 3 2008 1282 1289
20. J.M. Lopes de Faria, H. Russ, and V.P. Costa Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy British Journal of Ophthalmology 86 7 2002 725 728 (Pubitemid 34713154)
21. X. Luo Hypoglycemia induces general neuronal death: whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro Investigative Ophthalmology and Visual Science 42 11 2001 2695 2705 (Pubitemid 32954882)
22. H.M. Nakagami, R. Yamamoto, K. Yoshimura, S.I. Taniyama, Y. Aoki, and M. Matsubara Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high d-glucose in human endothelial cells Diabetes 50 2001 1472 1481
23. D.M. Nathan Long-term complications of diabetes mellitus New England Journal of Medicine 328 23 1993 1676 1685 (Pubitemid 23157351)
24. T. Oshitari, and S. Roy Effect of early diabetes on retinal neuronal cell death and regeneration Investigative Ophthalmology and Visual Science 45 5 2004 3235
25. S. Satoh Photopic electroretinogram implicit time in diabetic retinopathy Japanese Journal of Ophthalmology 38 2 1994 178 184 (Pubitemid 24229587)
26. S.Z. Scalinci Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous Clinical Ophthalmology 5 2011 691 696
27. L.Q. Shen Rosiglitazone and delayed onset of proliferative diabetic retinopathy Archives of Ophthalmology 126 6 2008 793 799 (Pubitemid 351831328)
28. K.C. Silva Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes Diabetes 58 6 2009 1382 1390
29. E. Tamagno H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK Experimental Neurology 180 2 2003 144 155 (Pubitemid 36398169)
30. UKPDS Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
31. UKPDS Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group BMJ 317 7160 1998 703 713
32. Q. Wang Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina Diabetologia 53 6 2010 1227 1238
33. A. Wenzel Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor Investigative Ophthalmology and Visual Science 42 7 2001 1653 1659 (Pubitemid 32520761)
34. J.H. Yi PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms Brain Research 1244 2008 164 172
35. Y. Yoshida Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy Diabetes/Metabolism Research and Reviews 25 7 2009 678 686
36. X. Zhang Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression Current Eye Research 30 5 2005 395 403 (Pubitemid 40910820)
37. J. Zhang Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy Frontiers in Bioscience (Elite Ed) 2 2010 912 927
38. S.S. Zhu Wld(S) protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice Diabetologia 54 9 2011 2440 2450